2m 2m 2m 2m 2m 2m 2m
Cytokinetics (CYTK)
NASDAQ
$61.23$0.00 (0.00%)
Price as of Oct 23, 2026 7:39 PM EDT- $8.5BMarket Cap
- 5.88%1-Year Change
- BiotechnologyIndustry
Cytokinetics (CYTK)
$61.23$0.00 (0.00%)
CYTK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $61.23 | ||
Change | -$1.10 (-1.76%) | ||
Open | $62.01 | ||
High | $62.44 | ||
Low | $60.89 | ||
Previous Close | $62.33 | ||
Volume | 985,820 | ||
30-Day Average Volume | 1,983,008 | ||
1-Week Change | -1.16% | ||
1-Month Change | -6.96% | ||
1-Year Change | 5.88% | ||
3-Year Change | 92.06% | ||
5-Year Change | 65.35% | ||
Fundamentals | |||
Shares Outstanding | 139.0M | ||
Total Assets | $1.9B | ||
Market Cap | $8.5B | ||
Enterprise Value | $8.5B | ||
Period: QTR TTM FY | |||
Revenue | $25.3M | ||
Net Income | -$198.8M | ||
Free Cash Flow | -$164.2M | ||
EBIT | -$184.1M | ||
EBITDA | -$180.5M | ||
Net Working Capital | $1.0B | ||
EPS | -$1.50 | ||
Enterprise Value/EBITDA | -47 | ||
Enterprise Value/Revenue | 337 | ||
P/B | -49 | ||
P/E | -41 | ||
PEG | -4 | ||
Price/Free Cash Flow | -52 | ||
Price/Operating Cash Flow | -53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/25/2013 | ||
Earnings & Revenue